University of Michigan Rogel Cancer Center

Site:	University of Michigan Rogel Cancer Center	Go to their website
Address:	1500 East Medical Center Dr Floor B1, Reception E
City:	Ann Arbor
State:	MI
Zip:	48109
Country:	USA

Phase [asc]	Trial	Trial Status	Site Status	Drug	NCT#
3	A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy (StrateGIST 3)	Recruiting	Active	IDRX-42	NCT07218926
1/2	Study of the Safety, Pharmacokinetics and Efficacy of EDO-S101, in Patients With Advanced Solid Tumors	Completed	Closed	EDO-S101	NCT03345485